Federal Register of Legislation - Australian Government

Primary content

PB 30 of 2019 Other as made
This instrument amends Schedule 1 of the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015) to add, delete and alter listed pharmaceutical items and associated periods and circumstances.
Administered by: Health
Registered 30 Apr 2019

PB 30 of 2019

 

National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 4)

 

National Health Act 1953

___________________________________________________________________________

 

I, SEAN LANE, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated   29 April 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SEAN LANE

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health


 

___________________________________________________________________________

1          Name of Instrument

(1)          This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 4).

(2)          This Instrument may also be cited as PB 30 of 2019.

2          Commencement

This Instrument commences on 1 May 2019.

3          Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).

 


Schedule 1       Amendments

[1]        Schedule 1, after entry for Oxybutynin in the form Transdermal patches 36 mg, 8

insert:

Palbociclib

Capsule 75 mg

20

21

5

 

 

Capsule 100 mg

20

21

5

 

 

Capsule 125 mg

20

21

5

 

[2]        Schedule 1, after entry for Tiotropium with olodaterol

insert:

Tofacitinib

Tablet 5 mg

20

56

5